#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis acute Lennox-Gastaut syndrome Precursor T-lymphoblastic lymphoma/leukaemia recurrent Hypotransferrinaemia Gastric cancer Mantle cell lymphoma Follicle centre lymphoma follicular grade I, II – III Leukodystrophy Chronic myeloid leukaemia Anal fistula Pyruvate kinase deficiency anaemia Erdheim-Chester disease Ependymoma Glycogen storage disease type II Osteochondrodysplasia More trials…

    Learn about Rare Diseases

    Hepatoblastoma – Life with Disease Chordoma – Trials in Disease Cholangitis sclerosing Chordoma – Basic Information Glycogen storage disease type II – Treatment Combined immunodeficiency – Diagnostics Toxic epidermal necrolysis Hereditary angioedema – Trials in Disease Testicular leiomyosarcoma – Diagnostics Wiskott-Aldrich syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Thalidomide Nalbuphine Hydrochloride SECRETIN SYNTHETIC HUMAN ZIGAKIBART Hct116-A [18F]DED RIMIDUCID Lenzumestrocel Atrasentan Hydrochloride Hu5F9‐G4 Ribitol Amcenestrant Lovo-A Masupirdine Sotrovimab Allogeneic Faecal Microbiota Tiapride Metyrapone Emapalumab Englumafusp Alfa More therapies…

    Learn about Your Condition

    Petit mal epilepsy Dementia Alzheimer's type Procedural anxiety Hepatic adenoma Cachexia Urticaria cholinergic Rectal cancer Proteus syndrome Open angle glaucoma Hypotonia Actinic keratosis Retroperitoneal cancer Milk allergy Mixed-type liposarcoma Testis cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Immune System Diseases

  • Frexalimab versus Tacrolimus for Prevention of Kidney Transplant Rejection in Adult Kidney Transplant Recipients

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Frexalimab
    • Tacrolimus
    Austria Belgium Czechia Denmark Finland France +6

  • A study to evaluate the efficacy and safety of rilzabrutinib in adults with active IgG4-related disease

    Recruiting

    3 1
    Belgium France Germany Italy The Netherlands Poland +2

  • A study of mirikizumab levels in breast milk of breastfeeding women with ulcerative colitis or Crohn’s disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Mirikizumab
    Denmark Germany Italy Poland Spain

  • A study to evaluate the efficacy and safety of obinutuzumab compared to prednisolone in adults with newly onset minimal change disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Nephropathy
    Investigated Drugs:
    • Obinutuzumab
    • Betamethasone Sodium Phosphate
    • Rituximab
    Austria France Germany

  • A study to evaluate the effectiveness and safety of AZD1163 in adults with moderate to severe rheumatoid arthritis

    Recruiting

    2 1
    Investigated Drugs:
    • AZD1163
    Bulgaria Germany Hungary Poland Spain

  • A study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma

    Recruiting

    2 1
    Austria Belgium Germany Italy Poland Romania +2
Previous Page
1 2 3 4 5 … 131
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!